Zhenoluten: Complete Guide: Mechanism, Dosing, and Clinical Evidence
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
A complete guide to Zhenoluten, a natural peptide bioregulator for the female reproductive system, covering its mechanism of action, dosing recommendations, and clinical evidence.
Zhenoluten: A Natural Peptide Bioregulator for Female Reproductive Health
Zhenoluten is a peptide complex derived from the ovaries of young animals, designed to support and regulate the female reproductive system. As a peptide bioregulator, it is part of a class of substances that aim to restore normal cellular function and promote tissue-specific regeneration. This guide provides a comprehensive overview of Zhenoluten, including its mechanism of action, recommended dosing, and the clinical evidence supporting its use.
Mechanism of Action: Restoring Ovarian Function
The primary action of Zhenoluten is to regulate the function of the ovaries at a cellular level. The peptide complex contains specific amino acid chains that are believed to interact with the DNA of ovarian cells, influencing gene expression and protein synthesis [1]. This process helps to normalize the menstrual cycle, improve the quality of egg cells, and restore the natural hormonal balance of the female body. By optimizing the metabolism of ovarian cells, Zhenoluten can help to improve their resilience and function, which can be particularly beneficial for women experiencing age-related decline in reproductive health or those with ovarian dysfunction.
Clinical studies have suggested that Zhenoluten can help to restore the normal function of the ovaries, even in cases of premature ovarian failure [2]. Its ability to promote the maturation of eggs and regulate hormone production makes it a promising supplement for women seeking to enhance their fertility and overall reproductive well-being.
Dosing and Clinical Evidence
Zhenoluten has been the subject of clinical studies, primarily in Russia, which have demonstrated its effectiveness in restoring female reproductive function. These studies have shown that Zhenoluten can be beneficial for a variety of conditions, including menstrual irregularities, menopausal symptoms, and infertility [3]. A key study on Zhenoluten showed its ability to normalize the menstrual cycle and improve the hormonal profile in women with ovarian insufficiency.
| Condition | Potential Benefit of Zhenoluten |
| :--- | :--- |
| Menstrual Irregularities | Normalizes cycle length and regularity |
| Menopausal Symptoms | Reduces hot flashes and other symptoms |
| Infertility | Improves egg quality and ovarian function |
| Ovarian Dysfunction | Restores normal hormonal balance |
The recommended dosage for Zhenoluten is typically 1-2 capsules, one to two times per day before meals, for a course of 10-30 days. It is often recommended to repeat the course every 3-6 months to maintain the positive effects. Zhenoluten is considered safe and well-tolerated, with no significant side effects reported in clinical trials. However, as with any supplement, it is advisable to consult with a healthcare professional before starting treatment.
Key Takeaways
Zhenoluten is a natural peptide bioregulator for the female reproductive system.
It works by regulating cellular function in the ovaries.
Clinical studies have shown its effectiveness in treating menstrual irregularities, menopausal symptoms, and infertility.
It is considered safe and well-tolerated.
> Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.
References
[1] Khavinson, V. K. (2002). Peptides and Ageing. Nova Science Publishers.
[2] Anti-Aging Systems. (n.d.). Report on the results of clinical study of peptide bioregulator Zhenoluten. Retrieved from https://www.antiaging-systems.com/articles/report-on-the-results-of-clinical-study-of-peptide-bioregulator-zhenoluten/
[3] Khavinson, V. K., & Kuznik, B. I. (2015). Peptide bioregulators: a new class of geroprotectors. Messages of the Russian Academy of Medical Sciences, 35(3), 269-276.
---